Pharmacotherapy is the core of management for schizophrenia, and provides an essential foundation upon which psychosocial strategies for recovery can be built.
When antipsychotic treatment is initiated in a patient with schizophrenia, two points need to be considered:
- Which medication will work best for this patient?
- What are the associated risks of using the medicine in this patient?
This article focuses on the use of atypical antipsychotics, which are now the mainstay of treatment for patients with schizophrenia.